Boston Scientific Executive and Leadership Team

Bernardo Del, the Director, Finance (Country & Chief Financial Officer (Mexico) at Boston Scientific, manages the fiscal health and operational budgeting for the Mexican market. This role involves executing financial planning, forecasting, and resource allocation to support the commercialization of medical devices within the region. By analyzing market trends and cost structures, the Director, Finance (Country & Chief Financial Officer (Mexico) optimizes capital deployment to maximize regional profitability. Bernardo Del coordinates with local leadership to ensure compliance with international accounting standards while driving growth initiatives. The Director, Finance (Country & Chief Financial Officer (Mexico) monitors cash flow and investment performance to maintain the financial stability required for sustained expansion. Through rigorous financial oversight, Del ensures that the company maintains a competitive edge in the Latin American healthcare sector. This leadership function directly impacts the ability of the organization to deliver life-saving technologies to hospitals and clinics throughout the region.

Daniel Brennan, the Executive Vice President & Chief Financial Officer at Boston Scientific, oversees the global financial strategy, capital structure, and investor relations for the entire organization. This leadership role involves directing enterprise-wide financial planning and analysis to ensure the efficient allocation of resources across the MedSurg and Cardiovascular segments. By managing the balance sheet and evaluating potential mergers or acquisitions, the Executive Vice President & Chief Financial Officer supports the long-term growth objectives of the company. Daniel Brennan collaborates with the Board of Directors to communicate financial performance and strategic priorities to shareholders. The Executive Vice President & Chief Financial Officer maintains a focus on operational efficiency, implementing cost-management programs that enhance profitability without compromising the quality of medical device manufacturing. Through disciplined financial stewardship, Brennan secures the capital necessary to fund ongoing research and development, ensuring the company remains at the forefront of medical innovation.

June Chang, the President (Greater China) at Boston Scientific, directs the overall business strategy, market development, and operational execution within the Greater China region. This role involves overseeing the commercialization of the entire portfolio of medical devices, ensuring that the company meets the unique needs of the local healthcare market. By managing relationships with government stakeholders and hospital networks, the President (Greater China) facilitates the expansion of the company footprint in this critical growth area. June Chang leads the regional team in executing sales and marketing strategies that drive market share and brand awareness. The President (Greater China) monitors the regulatory landscape and competitive environment to ensure that the organization remains agile and responsive to market changes. Through the strategic leadership of regional operations, Chang ensures that the company delivers high-quality medical technologies to healthcare providers, contributing to the global mission of improving patient outcomes.

Rafael Carbunaru, the Chief Technology Officer, Neuromodulation at Boston Scientific, directs the research and development of advanced neurostimulation platforms. This leadership role involves architecting next-generation hardware and software solutions to treat chronic pain and neurological conditions. By overseeing the engineering teams, Carbunaru ensures the seamless integration of complex electronic components into minimally invasive devices. The Chief Technology Officer, Neuromodulation collaborates with clinical researchers to translate scientific breakthroughs into scalable manufacturing processes. Rafael Carbunaru maintains a focus on technical excellence, ensuring that all product development cycles align with rigorous safety standards and regulatory requirements. Through the continuous refinement of stimulation algorithms, Carbunaru drives innovation that significantly improves patient quality of life. This strategic oversight supports the broader mission of delivering high-impact medical technologies to healthcare providers across global markets, solidifying the company position as a leader in the interventional neuromodulation space.

Joseph Bockover, the Manager, Area Business & Strategy Chief of Staff at Boston Scientific, coordinates strategic initiatives and operational workflows across the business units. This role involves facilitating communication between executive leadership and functional teams to ensure alignment with corporate goals. By managing complex projects and streamlining internal processes, the Manager, Area Business & Strategy Chief of Staff enhances organizational agility and decision-making speed. Joseph Bockover analyzes market data to support the development of long-term business strategies, particularly regarding the commercialization of minimally invasive technologies. The Manager, Area Business & Strategy Chief of Staff monitors key performance indicators to track progress on strategic objectives and identifies opportunities for operational improvement. Through the effective management of cross-functional teams, Bockover ensures that the company maintains a cohesive approach to market challenges. This leadership function provides the structural support necessary for the organization to execute its mission of improving patient outcomes globally.

Deniz Özgünay, the Commercial Excellence Analyst and Chief of Staff - Growth Emerging Markets at Boston Scientific, drives the strategic expansion of medical device sales across high-growth international territories. This role involves analyzing market penetration data and optimizing sales force effectiveness to capture new opportunities in emerging healthcare systems. By coordinating with regional managers, the Commercial Excellence Analyst and Chief of Staff - Growth Emerging Markets ensures that commercial strategies align with local clinical needs and regulatory environments. Deniz Özgünay manages the operational cadence for the leadership team, facilitating the execution of growth initiatives that expand the reach of the company portfolio. The Commercial Excellence Analyst and Chief of Staff - Growth Emerging Markets evaluates competitive dynamics to refine pricing and distribution models. Through data-driven insights, Özgünay supports the scaling of operations in diverse markets, ensuring that healthcare providers receive the necessary support to utilize advanced interventional technologies effectively.

Laura Koep, the Vascular Strategy Lead Chief of Staff at Boston Scientific, directs the strategic planning for the vascular product portfolio, focusing on the development and commercialization of catheters and stents. This role involves synthesizing clinical insights and market research to guide the long-term roadmap for vascular interventions. By overseeing cross-functional collaboration between product development and marketing teams, the Vascular Strategy Lead Chief of Staff ensures that new technologies meet the evolving needs of interventional cardiologists. Laura Koep manages the strategic agenda for the vascular business unit, facilitating the execution of initiatives that drive market share growth. The Vascular Strategy Lead Chief of Staff monitors competitive trends and regulatory shifts to maintain the leadership position of the company in the vascular space. Through the alignment of internal resources and external partnerships, Koep supports the delivery of innovative solutions that improve patient outcomes in cardiovascular care.

Ronald Morton, the Chief Medical Officer at Boston Scientific, provides clinical leadership and oversight for the development and safety of the entire medical device portfolio. This role involves guiding the clinical trial strategy and ensuring that all products meet the highest standards of efficacy and patient safety. By collaborating with regulatory bodies and healthcare professionals, the Chief Medical Officer ensures that the company maintains a deep understanding of clinical requirements across all interventional specialties. Ronald Morton evaluates the medical impact of new technologies, providing the scientific rigor necessary to support product commercialization. The Chief Medical Officer leads the medical affairs team in communicating clinical data to the broader medical community, fostering trust and adoption of advanced solutions. Through the integration of clinical expertise into the product lifecycle, Morton ensures that the company remains committed to its mission of improving patient lives through safe and effective medical innovation.

Scott Kreiner, the Chief Medical Officer, Neuromodulation at Boston Scientific, leads the clinical strategy and medical research for the neuromodulation business unit. This role involves designing clinical studies to validate the efficacy of neurostimulation devices in treating chronic pain and neurological disorders. By working closely with the engineering and product teams, the Chief Medical Officer, Neuromodulation ensures that clinical insights inform the design and development of next-generation therapies. Scott Kreiner manages relationships with key opinion leaders in the medical community to foster collaboration and drive the adoption of innovative neuromodulation solutions. The Chief Medical Officer, Neuromodulation oversees the safety monitoring of all clinical programs, ensuring compliance with global regulatory standards. Through the rigorous evaluation of clinical data, Kreiner supports the expansion of the neuromodulation portfolio, ultimately helping the company deliver life-changing treatments to patients suffering from complex neurological conditions.

Vincent Fischetti, the Regional Executive at Boston Scientific, manages the operational performance and commercial success of the company across a designated geographic region. This role involves directing the sales and distribution networks to ensure that healthcare providers have consistent access to the full range of minimally invasive technologies. By overseeing regional market strategy, the Regional Executive aligns local operations with the global mission of the organization. Vincent Fischetti coordinates with hospital systems and clinical leaders to identify opportunities for partnership and service expansion. The Regional Executive monitors regional market trends and competitive activity to adjust commercial tactics in real-time. Through the effective management of regional teams, Fischetti drives revenue growth and operational efficiency. This leadership function ensures that the company maintains a strong presence in the region, supporting the delivery of advanced medical solutions that enhance patient care and clinical outcomes.